These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K; Sasaki J; Arakawa K Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571 [TBL] [Abstract][Full Text] [Related]
3. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin. Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533 [TBL] [Abstract][Full Text] [Related]
4. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide]. Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435 [TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia. Stohler R; Keller U; Riesen WF Eur J Clin Pharmacol; 1989; 37(2):199-203. PubMed ID: 2507323 [TBL] [Abstract][Full Text] [Related]
6. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia]. Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857 [TBL] [Abstract][Full Text] [Related]
7. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators. Simons LA Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112 [TBL] [Abstract][Full Text] [Related]
8. Effects of low-dose simvastatin therapy on serum lipid levels in patients with moderate hypercholesterolemia: a 12-month study. The Simvastatin Study Group. Itoh T; Matsumoto M; Hougaku H; Handa N; Tsubakihara Y; Yamada Y; Imaizumi M; Hoshi M; Shimazu Y; Hori M; Kawamori R; Ueda N; Fusamoto H; Kamada T Clin Ther; 1997; 19(3):487-97. PubMed ID: 9220213 [TBL] [Abstract][Full Text] [Related]
9. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW; Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001 [TBL] [Abstract][Full Text] [Related]
10. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901 [TBL] [Abstract][Full Text] [Related]
11. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia. Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548 [TBL] [Abstract][Full Text] [Related]
12. The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis. Bach LA; Cooper ME; O'Brien RC; Jerums G J Am Geriatr Soc; 1990 Jan; 38(1):10-4. PubMed ID: 2404052 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392 [TBL] [Abstract][Full Text] [Related]
14. [The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia]. Fricker J; Douste-Blazy P; Drouin P; De Gennes JL; Dachet C; Keller U Presse Med; 1990 Dec; 19(42):1927-30. PubMed ID: 2147752 [TBL] [Abstract][Full Text] [Related]
15. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia]. Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363 [TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia. Crook D; Bruce R; Worthington M; Mulcahy D; Patterson D; Wynn V Cardiovasc Drugs Ther; 1992 Dec; 6(6):633-9. PubMed ID: 1292582 [TBL] [Abstract][Full Text] [Related]
17. Comparative effects of simvastatin and pravastatin on cholesterol synthesis in patients with primary hypercholesterolemia. Feillet C; Farnier M; Monnier LH; Percheron C; Colette C; Descomps B; Crastes De Paulet A Atherosclerosis; 1995 Dec; 118(2):251-8. PubMed ID: 8770319 [TBL] [Abstract][Full Text] [Related]
18. Crossover trial of simvastatin versus pravastatin in patients with primary hypercholesterolemia. Sasaki S; Sawada S; Nakata T; Itoh H; Takeda K; Nakagawa M; Kuriyama K J Cardiovasc Pharmacol; 1997 Jul; 30(1):142-7. PubMed ID: 9268234 [TBL] [Abstract][Full Text] [Related]
19. Safety, tolerability, and efficacy of simvastatin and fenofibrate--a multicenter study. Simvastatin-Fenofibrate Study Group. Ziegler O; Drouin P Cardiology; 1990; 77 Suppl 4():50-7. PubMed ID: 2073672 [TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients. Lansberg PJ; Mitchel YB; Shapiro D; Kastelein JJ; Altman R; Jerums G; Bolzano K; Giannini S; Davignon J; DeWailly P Atherosclerosis; 1995 Aug; 116(2):153-62. PubMed ID: 7575771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]